Schizophrenia
Welcome,         Profile    Billing    Logout  
 86 Companies   137 Products   137 Products   85 Mechanisms of Action   4 Trials   2019 News 


«12345678910111213...3940»
  • ||||||||||  Trial completion, Trial primary completion date:  Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder (clinicaltrials.gov) -  Sep 20, 2017   
    P=N/A,  N=350, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Trial completion, Phase classification, Trial initiation date, Trial primary completion date:  DCS: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (clinicaltrials.gov) -  Sep 19, 2017   
    P,  N=2, Completed, 
    Recruiting --> Completed Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Jul 2017 --> Sep 2016
  • ||||||||||  Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
    Trial completion, Enrollment change:  Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) -  Sep 13, 2017   
    P1/2,  N=27, Completed, 
    Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Jul 2017 --> Sep 2016 Suspended --> Completed | N=60 --> 27
  • ||||||||||  L-threonic acid magnesium salt (NRCT-101) / Neurocentria
    Trial completion, Phase classification, Trial primary completion date:  Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia (clinicaltrials.gov) -  Sep 5, 2017   
    P2,  N=60, Completed, 
    Active, not recruiting --> Completed | N=30 --> 21 Recruiting --> Completed | Phase classification: P4 --> P2 | Trial primary completion date: Mar 2018 --> Aug 2017
  • ||||||||||  metformin / Generic mfg.
    Enrollment change, Trial initiation date:  Metformin for Weight Loss in Schizophrenia (clinicaltrials.gov) -  Sep 1, 2017   
    P=N/A,  N=12, Terminated, 
    Recruiting --> Completed | Phase classification: P4 --> P2 | Trial primary completion date: Mar 2018 --> Aug 2017 N=15 --> 12 | Initiation date: May 2000 --> May 2008
  • ||||||||||  Clinical protocol, Trial completion, Trial primary completion date:  Psychosis-Associated Neuroinflammation in Schizophrenia (clinicaltrials.gov) -  Aug 31, 2017   
    P=N/A,  N=106, Completed, 
    Trial primary completion date: Jun 2017 --> Mar 2017 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2017
  • ||||||||||  Trial completion, Trial primary completion date:  Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus (clinicaltrials.gov) -  Aug 28, 2017   
    P=N/A,  N=200, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2017 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Mar 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  Exercise and Cognitive Training (clinicaltrials.gov) -  Aug 10, 2017   
    P=N/A,  N=30, Active, not recruiting, 
    Trial primary completion date: Jul 2017 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2017
  • ||||||||||  Trial completion:  tDCS to Enhance Cognitive Training in Schizophrenia (clinicaltrials.gov) -  Aug 8, 2017   
    P1/2,  N=52, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2017 Recruiting --> Completed
  • ||||||||||  Trial completion, Trial initiation date, Trial primary completion date:  Early Medication Discontinuation and Long-term Clinical Outcome in FEP (clinicaltrials.gov) -  Aug 7, 2017   
    P=N/A,  N=178, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Initiation date: Jul 2013 --> Nov 2013 | Trial primary completion date: Mar 2015 --> Dec 2014
  • ||||||||||  Enrollment change:  First Time in Human Study With GSK1018921 (clinicaltrials.gov) -  Aug 4, 2017   
    P1,  N=27, Completed, 
    Recruiting --> Completed | Initiation date: Jul 2013 --> Nov 2013 | Trial primary completion date: Mar 2015 --> Dec 2014 N=54 --> 27
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Cognitive Skills Training Using Computer for Patients With Severe Mental Illness (clinicaltrials.gov) -  Jul 21, 2017   
    P4,  N=448, Completed, 
    Enrolling by invitation --> Completed Recruiting --> Completed | Phase classification: P2/3 --> P4 | N=200 --> 448 | Trial primary completion date: Dec 2012 --> Dec 2016
  • ||||||||||  Trial primary completion date:  Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) -  Jul 7, 2017   
    P1/2,  N=18, Terminated, 
    Recruiting --> Completed Trial primary completion date: Jul 2017 --> Jun 2016
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  The Role of Norepinephrine in Emotional Processing (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=216, Completed, 
    Phase classification: P2 --> P2a Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Timing of Voluntary Movement in Patients With Schizophrenia (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=42, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date, Patient reported outcomes:  CIAS PRO: Schizophrenia Cognition Scale Development (clinicaltrials.gov) -  Jun 21, 2017   
    P=N/A,  N=102, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jul 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Effects of Systematic Patient Feedback on Therapy Outcome (clinicaltrials.gov) -  Jun 14, 2017   
    P=N/A,  N=170, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Jun 2018 --> Jun 2017
  • ||||||||||  eszopiclone / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Effects of Eszopiclone on Sleep and Memory in Schizophrenia (clinicaltrials.gov) -  Jun 14, 2017   
    P=N/A,  N=59, Completed, 
    Recruiting --> Completed | Trial primary completion date: Jun 2018 --> Jun 2017 Recruiting --> Completed | N=80 --> 59 | Trial primary completion date: Jun 2015 --> Dec 2015
  • ||||||||||  metformin / Generic mfg.
    Trial primary completion date:  Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness (clinicaltrials.gov) -  Jun 14, 2017   
    P4,  N=24, Recruiting, 
    Recruiting --> Completed | N=80 --> 59 | Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jun 2017 --> Dec 2017
  • ||||||||||  olanzapine / Generic mfg., sertraline / Generic mfg.
    Enrollment closed, Enrollment change:  STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) -  Jun 9, 2017   
    P4,  N=269, Active, not recruiting, 
    Trial primary completion date: Jun 2017 --> Dec 2017 Recruiting --> Active, not recruiting | N=392 --> 269
  • ||||||||||  Trial completion, Trial primary completion date:  APUS e-Cigs: Electronic Cigarettes in Smokers With Mental Illness (clinicaltrials.gov) -  May 16, 2017   
    P=N/A,  N=50, Completed, 
    N=240 --> 298 Not yet recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2017
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Healthy Bodies, Healthy Kids (clinicaltrials.gov) -  May 12, 2017   
    P=N/A,  N=50, Completed, 
    Recruiting --> Completed Recruiting --> Completed | N=126 --> 50 | Trial primary completion date: Dec 2016 --> Mar 2017
  • ||||||||||  Trial primary completion date:  SPA: A System for Preference Assessment in Mental Health (clinicaltrials.gov) -  May 2, 2017   
    P=N/A,  N=90, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jan 2017 --> Jul 2017
  • ||||||||||  amisulpride / Generic mfg.
    Enrollment change, Trial termination:  Optimisation of Antipsychotic Drug Use in Older People (clinicaltrials.gov) -  Apr 19, 2017   
    P4,  N=64, Terminated, 
    Trial primary completion date: Dec 2014 --> Dec 2015 N=120 --> 64 | Recruiting --> Terminated; Failure to recruit people with very late onset schizophrenia like psychosis
  • ||||||||||  clozapine / Generic mfg.
    Trial completion:  Vitamin D for Schizophrenia (clinicaltrials.gov) -  Apr 13, 2017   
    P=N/A,  N=47, Completed, 
    N=120 --> 64 | Recruiting --> Terminated; Failure to recruit people with very late onset schizophrenia like psychosis Active, not recruiting --> Completed